Centessa Pharmaceuticals
CNTA
#4162
Rank
NZ$3.65 B
Marketcap
$27.71
Share price
-2.65%
Change (1 day)
75.61%
Change (1 year)

P/S ratio for Centessa Pharmaceuticals (CNTA)

P/S ratio as of March 2025 (TTM): 304

According to Centessa Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.17. At the end of 2024 the company had a P/S ratio of 296.

P/S ratio history for Centessa Pharmaceuticals from 2022 to 2024

PS ratio at the end of each year

Year P/S ratio Change
2024296161.23%
2023113
2022N/A